TotalMarketCap

Valion Bio

VBIONasdaq United StatesHealth CareBiotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$1.066 M

$0.49 -4.35%

Close of 6 Nov 2026

As of 6 Nov 2026, Valion Bio (VBIO) has a market capitalization of $1.07M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$780.0K

#3479 by revenue

Earnings

-$8.88M

Loss-making

Shares outstanding

22,189,739

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 26 →
  1. #22IridexIRIX$12.1M
  2. #23ENDRA Life SciencesNDRA$7.30M
  3. #24NuwellisNUWE$1.87M
  4. #25Nexalin TechnologyNXL$1.61M
  5. #26Valion BioVBIO$1.07M

What if Valion Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$13,099,086

Per share 26,484,202× higher

Bitcoin $1.53T

$708,768.76

Per share 1,433,014× higher

Apple $5.02T

$2,326,822

Per share 4,704,451× higher

Or at a round number

$2.00M$5.00M$10.0M$20.0M

Where these numbers come from

Share counts and financials for Valion Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.